Abstract
Children with hematologic and oncologic health conditions are at risk of impaired skeletal muscle strength, size, and neuromuscular activation that may limit gross motor performance. A comprehensive assessment of neuromuscular function of these children is essential to identify the trajectory of changes in skeletal muscle and to prescribe therapeutic exercise and monitor its impact. Therefore, this review aims to (a) define fundamental properties of skeletal muscle; (b) highlight methods to quantify muscle strength, size, and neuromuscular activation; (c) describe mechanisms that contribute to muscle strength and gross motor performance in children; (d) recommend clinical assessment measures; and (e) illustrate comprehensive muscle assessment in children using examples of sickle cell disease and musculoskeletal sarcoma.
Funder
NIAMS
Foundation for Physical Therapy Research
Gladys E. Wadsworth Physical Therapy Research Fund
Subject
Pediatrics, Perinatology and Child Health
Reference141 articles.
1. (1986). Ostering L Isokinetic Dynamometry: Implications for Muscle Testing and Rehabilitation. Exerc. Sport Sci. Rev., 144, 45–79.
2. White Paper: Movement System Diagnoses in Neurologic Physical Therapy;Hedman;J. Neurol. Phys. Ther.,2018
3. Movement System Diagnosis;J. Neurol. Phys. Ther.,2017
4. APTA (2014). Guide to Physical Therapist Practice 3.0, APTA.
5. How Sickle Cell Disease Impairs Skeletal Muscle Function: Implications in Daily Life;Merlet;Med. Sci. Sport Exerc.,2019
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献